Report cover image

Global Self-injections Market

Publisher Data Bridge Market Research
Published Sep 01, 2024
Length 553 Pages
SKU # DAABD19472230

Description

Global Self-injections Market


Global self-injection market is expected to reach USD 97.36 billion by 2031 from USD 46.18 billion in 2023, growing with a CAGR of 10.0% in the forecast period of 2024 to 2031.

Global Self-injections Market, By Product Type (Self-Injection Devices and Self-Injection Formulation), Dosage Form (Single Dose and Multi-Dose), Route of Administration (Subcutaneous, Intra muscular, and Others), Application (Autoimmune Diseases, Pain Management, Emergency Drugs, Oncology, Hormonal Disorders, and Others), Age Group (Adult, Geriatric, and Pediatric), Gender (Male and Female), Distribution Channel (Direct Tender, Hospital Pharmacy, Online Pharmacy, and Others), Country (U.S., Canada, Mexico, China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Indonesia, Australia, Philippines, New Zealand, Taiwan, Vietnam, Rest of Asia-Pacific, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Denmark, Sweden, Norway, Poland, Finland, Rest of Europe, South Africa, U.A.E., Egypt, Saudi Arabia, Israel, Kuwait, Oman, Qatar, Bahrain, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America) – Industry Trends and Forecast to 2031
Overview of Global Self-Injections Market Dynamics:
Driver
• Rising prevalence of chronic disease
Restraint
• High cost of self injectors
Opportunity
• Government initiatives to self-injections
Market Players:
The key market players operating in the global self-injection market are listed below:
• Novo Nordisk A/S
• Johnson & Johnson Services, Inc.
• Biogen
• Amgen Inc.
• Sanofi
• AbbVie Inc.
• YPSOMED
• BD
• AstraZeneca
• AptarGroup, Inc.
• Bayer AG
• Bausch Health Companies Inc.
• Boehringer Ingelheim International GmBH
• Credence Medsystems, Inc.
• Dali Medical Devices
• Enable Injections
• E3D Elcam Drug Delivery Devices
• F. Hoffmann-La Roche Ltd
• GSK plc
• Gerresheimer AG
• Haselmeier
• Ipsen Biopharmaceuticals, Inc.
• Lilly
• Midas Pharma GmBH
• Merck & Co., Inc.
• Novartis AG
• Nemera
• OVAL MEDICAL TECHNOLOGIES LTD. (SMC LIMITED)
• Owen Mumford
• Pfizer Inc.
• Philips-Medisize
• PharmaJet
• PenJet
• Recipharm AB
• SCHOTT PHARMA
• SHL Medical AG
• Société Industrielle de Sonceboz SA
• Terumo Corporation
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals Industries Ltd.
• UCB Pharma
• West Pharmaceutical Service

Table of Contents

553 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Self-injections Market
1.4 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Therapeutics Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market Application Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Customizations
5 Global Self-injections Market: Regulations
5.1 Regulatory Authorities In The Asia-pacific Region
5.1.1 Australia
5.1.2 China
5.1.3 India
5.2 Regulatory Submissions
5.2.1 Pre-submission Activities
5.2.2 Development Of Technical Documentation
5.3 Clinical Evaluation
5.4 Regulatory Submission Preparation
5.5 Submission To Regulatory Authority
5.6 Review And Evaluation By Regulatory Authority
5.7 Approval And Market Authorization
5.8 Post-market Surveillance
5.9 Renewal And Compliance
5.10 Asean Medical Device Directive (Amdd)
5.11 Adoption Of Global Standards (Iso And Iec)
5.12 Collaboration Via Apec Regulatory Harmonization Steering Committee
5.13 Clinical Data Harmonization
5.14 Common Technical Document (Ctd) Format
5.15 Post-market Surveillance And Reporting Harmonization
5.16 Mutual Recognition Agreements (Mras)
5.17 Training And Capacity Building Initiatives
5.18 North America Regulatory Scenario
5.19 Medical Device Classification
5.20 Regulatory Submissions
5.21 Europe Regulatory Scenario
5.22 Regulatory Submissions
5.23 Middle East And Africa Regulatory Scenario
5.24 South America Regulatory Scenario
5.25 International Harmonization
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Chronic Disease
6.1.2 Technological Advancement In Self Injections
6.1.3 Increase In Patient Autonomy
6.1.4 Rise In Mobile Health Applications
6.2 Restraints
6.2.1 High Cost Of Self Injectors
6.2.2 Regulatory Hurdles And Need For Proper Training For Self-injection Devices
6.3 Opportunities
6.3.1 Government Initiatives To Self-injections
6.3.2 Increased Research And Development For Self-injection
6.3.3 Growing Demand For Biologics And Personalized Medicine
6.4 Challenges
6.4.1 Patient Reluctance Towards Needles
6.4.2 Environmental Concerns With Self-injections
7 Global Self-injections Market, By Product Type
7.1 Overview
7.2 Self-injection Devices
7.3 Self-injection Formulation
8 Global Self-injections Market, By Dosage Form
8.1 Overview
8.2 Single Dose
8.3 Multi-dose
9 Global Self-injections Market, By Route Of Administration
9.1 Overview
9.2 Subcutaneous
9.3 Intra Muscular
9.4 Others
10 Global Self-injections Market, By Application
10.1 Overview
10.2 Autoimmune Diseases
10.3 Pain Management
10.4 Emergency Drugs
10.5 Oncology
10.6 Hormonal Disorders
10.7 Others
11 Global Self-injections Market, By Age Group
11.1 Overview
11.2 Adult
11.3 Geriatric
11.4 Pediatric
12 Global Self-injections Market, By Gender
12.1 Overview
12.2 Male
12.3 Female
13 Global Self-injections Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Hospital Pharmacy
13.4 Online Pharmacy
13.5 Others
14 Global Self-injections Market, By Region
14.1 Overview
14.2 Global
14.3 North America
14.4 Europe
14.5 Asia-pacific
14.6 South America
14.7 Middle East And Africa
15 Global Self-injections Market: Company Landscape
15.1 Company Share Analysis: Global
15.2 Company Share Analysis: North America
15.3 Company Share Analysis: Europe
15.4 Company Share Analysis: Asia-pacific
16 Swot Analysis
17 Company Profiles
17.1 Novo Nordisk
17.1.1 Company Snapshot
17.1.2 Revenue
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Johnson & Johnson Services, Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Biogen
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Product Portfolio
17.3.4 Recent Development
17.4 Amgen Inc.
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Sanofi
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Abbvie Inc.
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Company Share Analysis
17.6.4 Product Portfolio
17.6.5 Recent Development
17.7 Ypsomed
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Bd
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Astrazeneca
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Developments
17.10 Aptargroup, Inc.
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Developments
17.11 Bayer
17.11.1 Company Snapshot
17.11.2 Revenue
17.11.3 Product Portfolio
17.11.4 Recent Development
17.12 Bausch Health Companies Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.13 Boehringer Ingelheim International Gmbh
17.13.1 Company Snapshot
17.13.2 Revenue Analysis
17.13.3 Product Portfolio
17.13.4 Recent Developments
17.14 Credence Medsystems, Inc.
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.15 Dali Medical Devices
17.15.1 Company Sn.Apshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Enable Injections
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Developments
17.17 E3d Elcam Drug Delivery Devices
17.17.1 Company Snapshot
17.17.2 Product Portfolio
17.17.3 Recent Development
17.18 F. Hoffmann-la Roche Ltd
17.18.1 Company Snapshot
17.18.2 Revenue Analysis
17.18.3 Product Portfolio
17.18.4 Recent Development
17.19 Gsk Plc
17.19.1 Company Snapshot
17.19.2 Revenue Analysis
17.19.3 Product Portfolio
17.19.4 Recent Developments
17.20 Gerresheimer Ag
17.20.1 Company Snapshot
17.20.2 Revenue Analysis
17.20.3 Product Portfolio
17.20.4 Recent Developments
17.21 Haselmeier
17.21.1 Company Snapshot
17.21.2 Product Portfolio
17.21.3 Recent Development
17.22 Ipsen Biopharmaceuticals, Inc.
17.22.1 Company Snapshot
17.22.2 Revenue Analysis
17.22.3 Product Portfolio
17.22.4 Recent Development
17.23 Lilly
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Product Portfolio
17.23.4 Recent Development
17.24 Midas Pharma Gmbh
17.24.1 Company Snapshot
17.24.2 Product Portfolio
17.24.3 Recent Development
17.25 Merck & Co., Inc.,
17.25.1 Company Snapshot
17.25.2 Revenue Analysis
17.25.3 Product Portfolio
17.25.4 Recent Development
17.26 Novartis Ag
17.26.1 Company Snapshot
17.26.2 Revenue Analysis
17.26.3 Product Portfolio
17.26.4 Recent Developments
17.27 Nemera
17.27.1 Company Snapshot
17.27.2 Product Portfolio
17.27.3 Recent Development
17.28 Oval Medical Technologies Ltd. (Smc Limited)
17.28.1 Company Snapshot
17.28.2 Product Portfolio
17.28.3 Recent Development
17.29 Owen Mumford
17.29.1 Company Snapshot
17.29.2 Product Portfolio
17.29.3 Recent Development
17.30 Pfizer Inc.
17.30.1 Company Snapshot
17.30.2 Revenue Analysis
17.30.3 Product Portfolio
17.30.4 Recent Development
17.30.5 Recent Development
17.31 Philip Medsize
17.31.1 Company Snapshot
17.31.2 Product Portfolio
17.31.3 Recent Developments
17.32 Pharmajet.
17.32.1 Company Snapshot
17.32.2 Product Portfolio
17.32.3 Recent Development
17.33 Penjet
17.33.1 Company Snapshot
17.33.2 1.1.4 Product Portfolio
17.33.3 Recent Development
17.34 Recipharm Ab
17.34.1 Company Snapshot
17.34.2 Product Portfolio
17.34.3 Recent Developments
17.35 Schott Pharma
17.35.1 Company Snapshot
17.35.2 Product Portfolio
17.35.3 Recent Developments
17.36 Shl Medical Ag
17.36.1 Company Snapshot
17.36.2 Product Portfolio
17.36.3 Recent Development
17.37 Société Industrielle De Sonceboz Sa
17.37.1 Company Snapshot
17.37.2 Product Portfolio
17.37.3 Recent Development
17.38 Terumo Corporation
17.38.1 Company Snapshot
17.38.2 Revenue Analysis
17.38.3 Product Portfolio
17.38.4 Recent Development
17.39 Takeda Pharmaceutical Company Limited
17.39.1 Company Snapshot
17.39.2 Revenue Analysis
17.39.3 Product Portfolio
17.39.4 Recent Development
17.40 Teva Pharmaceuticals
17.40.1 Company Snapshot
17.40.2 Revenue
17.40.3 Product Portfolio
17.40.4 Recent Development
17.41 Ucb Pharma
17.41.1 Company Snapshot
17.41.2 Revenue
17.41.3 Product Portfolio
17.41.4 Recent Development
17.42 West Pharmaceutical Services
17.42.1 Company Snapshot
17.42.2 Revenue Analysis
17.42.3 Product Portfolio
17.42.4 Recent Developments
18 Questionnaire
19 Related Reports
Table 1 Global Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 2 Global Self-injection Devices In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 3 Global Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 4 Global Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 5 Global Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 6 Global Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 7 Global Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 8 Global Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 9 Global Self-injection Formulation In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 10 Global Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 11 Global Single Dose In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 12 Global Multi-dose In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 13 Global Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 14 Global Subcutaneous In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 15 Global Intra Muscular In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 16 Global Others In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 17 Global Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 18 Global Autoimmune Diseases In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 19 Global Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 20 Global Pain Management In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 21 Global Emergency Drugs In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 22 Global Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 23 Global Oncology In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 24 Global Hormonal Disorders In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 25 Global Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 26 Global Others In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 27 Global Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 28 Global Adult In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 29 Global Geriatric In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 30 Global Pediatric In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 31 Global Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 32 Global Male In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 33 Global Female In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 34 Global Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 35 Global Direct Tender In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 36 Global Hospital Pharmacy In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 37 Global Online Pharmacy In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 38 Global Others In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 39 Global Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 40 North America Self-injections Market, By Country, 2022-2031 (Usd Million)
Table 41 North America Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 42 North America Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 43 North America Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 44 North America Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 45 North America Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 46 North America Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 47 North America Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 48 North America Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 49 North America Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 50 North America Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 51 North America Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 52 North America Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 53 North America Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 54 North America Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 55 North America Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 56 North America Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 57 North America Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 58 U.S. Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 59 U.S. Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 60 U.S. Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 61 U.S. Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 62 U.S. Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 63 U.S. Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 64 U.S. Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 65 U.S. Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 66 U.S. Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 67 U.S. Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 68 U.S. Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 69 U.S. Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 70 U.S. Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 71 U.S. Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 72 U.S. Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 73 U.S. Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 74 U.S. Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 75 Canada Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 76 Canada Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 77 Canada Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 78 Canada Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 79 Canada Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 80 Canada Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 81 Canada Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 82 Canada Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 83 Canada Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 84 Canada Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 85 Canada Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 86 Canada Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 87 Canada Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 88 Canada Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 89 Canada Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 90 Canada Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 91 Canada Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 92 Mexico Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 93 Mexico Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 94 Mexico Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 95 Mexico Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 96 Mexico Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 97 Mexico Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 98 Mexico Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 99 Mexico Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 100 Mexico Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 101 Mexico Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 102 Mexico Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 103 Mexico Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 104 Mexico Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 105 Mexico Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 106 Mexico Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 107 Mexico Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 108 Mexico Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 109 Europe Self-injections Market, By Country, 2022-2031 (Usd Million)
Table 110 Europe Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 111 Europe Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 112 Europe Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 113 Europe Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 114 Europe Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 115 Europe Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 116 Europe Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 117 Europe Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 118 Europe Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 119 Europe Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 120 Europe Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 121 Europe Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 122 Europe Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 123 Europe Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 124 Europe Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 125 Europe Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 126 Europe Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 127 Germany Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 128 Germany Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 129 Germany Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 130 Germany Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 131 Germany Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 132 Germany Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 133 Germany Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 134 Germany Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 135 Germany Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 136 Germany Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 137 Germany Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 138 Germany Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 139 Germany Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 140 Germany Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 141 Germany Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 142 Germany Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 143 Germany Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 144 U.K. Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 145 U.K. Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 146 U.K. Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 147 U.K. Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 148 U.K. Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 149 U.K. Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us